ZENITHDRUG — Zenith Drugs Cashflow Statement
0.000.00%
- IN₹1.19bn
- IN₹1.67bn
- IN₹1.33bn
- 29
- 58
- 39
- 36
Annual cashflow statement for Zenith Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | PRESS | PRESS |
Standards: | IAS | IAS | — | — |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 44.1 | 66.6 | 133 | 95.1 |
Depreciation | ||||
Non-Cash Items | 21.4 | 23.1 | 0 | -2.92 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -27.2 | -150 | -304 | -176 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 51.5 | -47.7 | -158 | -54.7 |
Capital Expenditures | -52.4 | -55.7 | -53.3 | -321 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | -0.001 | 53 | 0 | 7.06 |
Sale of Fixed Assets | ||||
Sale/Maturity of Investment | ||||
Change in Net Intangibles | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -52.4 | -2.69 | -53.3 | -314 |
Financing Cash Flow Items | -20.9 | -23.1 | 0.001 | 0.001 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 12.4 | 49.9 | 297 | 284 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 11.5 | -0.476 | 85.5 | -84.8 |